A case series of serious and unexpected adverse drug reactions under treatment with cariprazine

Clin Case Rep. 2021 May 4;9(5):e04084. doi: 10.1002/ccr3.4084. eCollection 2021 May.

Abstract

Reporting of new or unexpected adverse drug reactions of medicines that are subject to additional monitoring ("black triangle" label), such as the antipsychotic drug cariprazine, is of paramount importance to improve pharmacotherapy safety.

Keywords: adverse drug reactions; cariprazine; dopamine supersensitivity psychosis; drug safety; hyperprolactinemia.

Publication types

  • Case Reports